Skip to main content

Animations

MJFF Publications

5251 - 5260 of 8620 Results
Title
Year
  • Year
  • 2015
  • 2012
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016
    Citation Count: 27
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 148
  • Summary Details
    OPEN
    Title: Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease
    Journal Name: Aging and disease
    Publisher: Aging and Disease
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.14336/ad.2024.0323
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158
    Citation Count: 2
  • Summary Details
    OPEN
    Title: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-52298-2
    Citation Count: 4
  • Summary Details
    OPEN
    Title: CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology
    Journal Name: Nature Immunology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41590-023-01604-z
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer
    Journal Name: Nature Metabolism
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42255-024-01118-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies
    Journal Name: Nature Biomedical Engineering
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41551-024-01242-2
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.